NCT06732349 Urinary Tubular Biomarkers for Chronic Kidney Disease
| NCT ID | NCT06732349 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Chronic Kidney Disease Stage 3 |
| Study Type | OBSERVATIONAL |
| Enrollment | 556 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 556 participants in total. It began in 2025-01-01 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Currently used tests for chronic kidney injury only assess the function of one part of the kidney: the filter called the glomerulus. The other part, called the tubule, is disregarded. Based on many previous studies, the investigators have good reason to assume that a better prediction of the course of chronic kidney disease by testing tubular function will be possible. This is important, for example, when patients need to be treated with kidney-protecting drugs.
Eligibility Criteria
Inclusion Criteria: * Chronic kidney disease stage 3 (eGFR 30-59ml/min) Exclusion Criteria: * Active glomerulonephritis treated with immunosuppression * Kidney transplant recipient * Current treatment with chemo- or immunotherapy for malignancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06732349 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Kidney Disease Stage 3. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06732349 currently recruiting?
Yes, NCT06732349 is actively recruiting participants. Contact the research team at s.beckmann@erasmusmc.nl for enrollment information.
Where is the NCT06732349 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands.
Who is sponsoring the NCT06732349 clinical trial?
NCT06732349 is sponsored by Erasmus Medical Center. The trial plans to enroll 556 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.